Initial Guide for Parents
This article explains various ways to foster your child's growth and well-being following an autism diagnosis.
Read MorePANS/PANDAS
PANS and PANDAS are autoimmune-triggered neuropsychiatric conditions that can dramatically change a child's behavior overnight. ARDIG uses immunotherapy and plasmapheresis to target the underlying immune dysfunction.
At a Glance
Sudden Onset
PANS/PANDAS is characterized by an abrupt, dramatic onset of OCD, tics, anxiety, or behavioral regression, often triggered by infection.
Personalized Assessment
Our team evaluates immune markers, infection history, and neuropsychiatric symptoms to design a targeted treatment protocol.
Treatment Locations
Immunotherapy and plasmapheresis treatments are delivered at ARDIG and partner institutions' facilities in Mexico, Peru, and the United States.
Measurable Outcomes
We track symptom reduction, behavioral improvements, and immune marker changes to measure treatment effectiveness.
Your Personalized Program
Every ARDIG patient receives a customized treatment plan built around their specific condition, goals, and medical history.
1
Medical Review
Submit your medical records for our team to review, and receive a free initial evaluation by one of our physicians. We assess your history, current status, and goals.
2
Custom Protocol Design
Our physicians design a treatment plan combining the most appropriate services for your specific needs.
3
Treatment at Our Facilities
Travel to one of our facilities in Mexico, Peru, or the United States for your treatment program, depending on your protocol.
4
Follow-Up & Monitoring
Your care continues remotely with scheduled check-ins and regular meetings with your ARDIG physician.
Relevant Services
Depending on your evaluation, your program may include one or more of the following therapies.
Immunotherapy
Targeted immune system modulation to restore balance and reduce chronic inflammation.
Coming SoonPlasmapheresis
Blood plasma filtration to remove harmful antibodies and inflammatory factors.
Coming SoonWhat to Expect
From your first consultation to ongoing follow-up, here is what the ARDIG journey looks like.
1
Free Consultation
Schedule a no-obligation call with one of our physicians to discuss your condition and treatment options.
2
Medical Evaluation
Our medical team reviews your records and determines if you are a candidate for our programs.
3
Schedule & Treatment
After medical evaluation and approval, choose your preferred treatment date and travel to one of our facilities for your scheduled treatment program.
4
Ongoing Care
After returning home, your ARDIG physician monitors your progress through scheduled telehealth appointments.
Featured Posts
FAQ
PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) are conditions where an immune response triggers sudden neuropsychiatric symptoms such as OCD, tics, anxiety, and behavioral regression in children.
ARDIG primarily uses immunotherapy and plasmapheresis to address the underlying immune dysfunction. Plasmapheresis filters harmful antibodies from the blood, while immunotherapy helps recalibrate the immune response. Treatment is tailored to each patient's specific immune profile.
Treatment eligibility depends on the individual child's condition and overall health. Our physicians evaluate each case to determine the safest and most effective approach. PANS/PANDAS most commonly affects school-age children.
Some families notice behavioral improvements within days to weeks after treatment, while others see gradual changes over several months. Response varies depending on symptom severity, duration of illness, and the specific immune dysfunction being addressed.
Yes. PANS/PANDAS treatment at ARDIG focuses on immunotherapy and plasmapheresis rather than stem cell therapy. These approaches directly target the autoimmune component driving the neuropsychiatric symptoms.
Your physician will recommend a follow-up plan based on your child's response to treatment. Some patients achieve lasting relief after an initial course, while others may benefit from additional sessions. Remote monitoring helps guide these decisions.